Haisco Pharmaceutical   Report issue

Founded: Liaoning China (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2014
NCT04033939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Haisco Pharmaceutical(Australia) Pty Ltd. | Haisco Pharmaceutical Group Co., Ltd. | Haisco-USA Pharmaceuticals, Inc. | Sichuan Haisco Pharmaceutical Group Co., Ltd | Sichuan Haisco Pharmaceutical Group Co., Ltd.